New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview
- 1 November 1999
- journal article
- review article
- Published by Elsevier in Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie
- Vol. 322 (11) , 959-966
- https://doi.org/10.1016/s0764-4469(00)87193-0
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- CD8-suppressor factor and β-chemokine function as a complementary mechanism to cognate immunityImmunology Letters, 1999
- Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + LymphocytesScience, 1999
- Fusion-Competent Vaccines: Broad Neutralization of Primary Isolates of HIVScience, 1999
- Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.Journal of Clinical Investigation, 1998
- Memory Cytotoxic T Lymphocyte Responses in Human Immunodeficiency Virus Type 1 (HIV-1)-Negative Volunteers Immunized with a Recombinant Canarypox Expressing gp160 of HIV-1 and Boosted with a Recombinant gp160The Journal of Infectious Diseases, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env GeneThe Journal of Infectious Diseases, 1995
- Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cellsThe Lancet, 1995
- Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef GeneScience, 1992
- CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus ReplicationScience, 1986